Filing Details

Accession Number:
0001567619-19-020298
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-01 16:34:51
Reporting Period:
2019-10-21
Accepted Time:
2019-11-01 16:34:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505497 Biorestorative Therapies Inc. BRTX Services-Misc Health & Allied Services, Nec (8090) 911835664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1677513 Dale Broadrick 3003 Brick Church Pike
Nashville TN 37207
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-21 215,000 $0.11 7,629,732 No 4 P Direct
Common Stock Acquisiton 2019-10-22 36,213 $0.14 7,665,945 No 4 P Direct
Common Stock Acquisiton 2019-10-23 6,500 $0.14 7,672,445 No 4 P Direct
Common Stock Acquisiton 2019-10-25 151,000 $0.14 7,823,445 No 4 P Direct
Common Stock Acquisiton 2019-10-28 1,000 $0.17 7,824,445 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrant to acquire Common Stock $0.15 2019-02-19 2024-02-19 500,000 500,000 Direct
Common Stock Warrant to acquire Common Stock $0.15 2019-02-19 2024-02-19 500,000 500,000 Direct
Common Stock Warrant to acquire Common Stock $0.15 2019-05-07 2024-05-07 555,556 555,556 Direct
Common Stock Warrant to acquire Common Stock $0.15 2019-05-07 2024-05-07 555,555 555,555 Direct
Common Stock Warrant to acquire Common Stock $0.20 2019-10-16 2024-10-16 3,333,333 3,333,333 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-02-19 500,000 500,000 Direct
2024-02-19 500,000 500,000 Direct
2024-05-07 555,556 555,556 Direct
2024-05-07 555,555 555,555 Direct
2024-10-16 3,333,333 3,333,333 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.10 to $0.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $0.14 to $0.15 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.